Ultravate
Active Ingredient(s): HalobetasolFDA Approved: * December 17, 1990
Pharm Company: * WESTWOOD SQUIBB
Category: Skin Care
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Ultravate Overview
Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4] Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed]...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ulobetasol
Recent Ultravate Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Halobetasol
- Cream: 0.05%
- Lotion: 0.05%
- Ointment: 0.05%
NDC Database Records for Ultravate: (3 results)
Sorted by National Drug Code- 10631-102 Ultravate .5 mg/g Topical Ointment by Ranbaxy Laboratories Inc.
- 10631-103 Ultravate .5 mg/g Topical Cream by Ranbaxy Laboratories Inc.
- 10631-122 Ultravate .5 mg/g Topical Lotion by Ranbaxy Laboratories, Inc.
Other drugs which contain Halobetasol or a similar ingredient: (3 results)
- HALOBETASOL
- DUOBRII Halobetasol Propionate + Tazarotene
- HALOBETASOL PROPIONATE + TAZAROTENE